13F Filings History of Versant Venture Management, LLC

Latest 13F report
Q4 2025 - 12 Feb 2026
Value $
$151,060,501
Signature - Title
Max Eisenberg - Chief Operating Officer
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by Versant Venture Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Versant Venture Management, LLC reported 7 stock holdings with total value $151,060,501 as of Q4 2025. Top holdings included GLUE, LENZ, JBIO, CRSP, and CTNM.

Notify me when Versant Venture Management, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 7 $151,060,501 $0 -$26,871,300 -$26,871,300 GLUE, LENZ, JBIO, CRSP, CTNM 13F-HR 12 Feb 2026, 16:08
Q3 2025 9 $212,452,986 +$123,757,843 -$22,665,807 +$101,092,036 LENZ, GLUE, JBIO, CRSP, SKYE 13F-HR 10 Nov 2025, 16:48
Q2 2025 8 $82,136,885 +$17,077,392 -$4,079,081 +$12,998,311 GLUE, CRSP, JBIO, SKYE, RPTX 13F-HR 11 Aug 2025, 16:35
Q1 2025 7 $60,208,868 +$2,588,207 -$2,926,637 -$338,430 GLUE, CRSP, CTNM, SKYE, RPTX 13F-HR 07 May 2025, 16:24
Q4 2024 7 $86,748,024 +$42,157,916 -$2,065,111 +$40,092,805 GLUE, CRSP, CTNM, SKYE, RPTX 13F-HR 11 Feb 2025, 18:03
Q3 2024 6 $63,573,512 $0 -$3,708,058 -$3,708,058 CRSP, CTNM, RPTX, SKYE, ADVM 13F-HR 08 Nov 2024, 17:18
Q2 2024 8 $77,296,930 +$16,168,866 -$1,043,130 +$15,125,736 CRSP, CTNM, SKYE, RPTX, ADVM 13F-HR 07 Aug 2024, 16:16
Q1 2024 7 $103,136,206 +$31,400,459 -$385,181,220 -$353,780,761 CRSP, SKYE, RPTX, GRTS, ADVM 13F-HR 03 May 2024, 16:35
Q4 2023 7 $388,843,408 $0 -$275,320 -$275,320 RYZB, CRSP, RPTX, GRTS, PASG 13F-HR 08 Feb 2024, 17:05
Q3 2023 8 $188,112,040 +$114,511,174 -$11,185,241 +$103,325,933 RYZB, RPTX, CRSP, ADVM, GRTS 13F-HR 03 Nov 2023, 17:10
Q2 2023 8 $84,298,028 +$28,001,631 $0 +$28,001,631 RPTX, CRSP, ADVM, GRTS, CBAY 13F-HR 09 Aug 2023, 16:55
Q1 2023 7 $47,972,612 $0 $0 $0 CRSP, GRTS, PASG, CBAY, ADVM 13F-HR 10 May 2023, 19:11
Q4 2022 7 $48,328,199 $0 -$121,000 -$121,000 CRSP, GRTS, PASG, CBAY, ADVM 13F-HR 09 Feb 2023, 16:13
Q3 2022 8 $52,455,000 $0 $0 $0 CRSP, GRTS, ADVM, ALGS, CBAY 13F-HR 10 Nov 2022, 16:35
Q2 2022 8 $65,230,000 $0 -$17,773,000 -$17,773,000 CRSP, PASG, GRTS, ADVM, UTRS 13F-HR 11 Aug 2022, 16:05
Q1 2022 10 $100,171,000 $0 $0 $0 CRSP, PASG, GRTS, CRNX, AKRO 13F-HR 10 May 2022, 16:25
Q4 2021 10 $186,975,000 +$8,603,000 -$29,914,359 -$21,311,359 GRTS, CRSP, PASG, ALGS, AKRO 13F-HR 11 Feb 2022, 06:05
Q3 2021 11 $241,512,000 $0 -$5,922,582 -$5,922,582 CRSP, PASG, GRTS, ALGS, CRNX 13F-HR 12 Nov 2021, 16:30
Q2 2021 11 $301,807,000 $0 -$214,574,324 -$214,574,324 CRSP, PASG, ALGS, GRTS, ADVM 13F-HR 12 Aug 2021, 16:17
Q1 2021 11 $513,262,000 +$87,331,405 -$440,109,066 -$352,777,661 CRSP, PASG, ALGS, ADVM, GRTS 13F-HR 06 May 2021, 17:45
Q4 2020 12 $962,968,000 +$296,954,121 -$130,311,794 +$166,642,327 CRSP, NARI, ALGS, ADVM, FLXN 13F-HR 16 Feb 2021, 07:30
Q3 2020 11 $546,369,000 +$40,001,000 -$127,325,132 -$87,324,132 CRSP, ADVM, APRE, FLXN, CRNX 13F-HR 12 Nov 2020, 17:07
Q2 2020 12 $696,065,245 +$116,280,429 -$18,478,974 +$97,801,455 CRSP, ADVM, APRE, AKRO, CRNX 13F-HR 20 Jul 2020, 14:14
Q1 2020 9 $364,636,407 +$127,071,962 -$3,910,524 +$123,161,438 CRSP, ADVM, AKRO, VCYT, GRTS 13F-HR 28 Apr 2020, 12:36
Q4 2019 7 $331,845,612 $0 -$17,280,371 -$17,280,371 CRSP, VCYT, GRTS, OCUL, EYES 13F-HR 21 Jan 2020, 15:12
Q3 2019 8 $258,454,717 $0 -$29,585,501 -$29,585,501 CRSP, VCYT, GRTS, BOLD, OCUL 13F-HR 08 Oct 2019, 14:24
Q2 2019 9 $343,186,489 +$34,566,629 -$48,258,199 -$13,691,570 CRSP, VCYT, GRTS, BOLD, OCUL 13F-HR 12 Jul 2019, 06:05
Q1 2019 9 $303,568,716 +$22,861,300 -$18,537,554 +$4,323,746 CRSP, VCYT, BOLD, CBAY, OCUL 13F-HR 05 Apr 2019, 14:25
Q4 2018 10 $202,020,917 $0 $0 $0 CRSP, VCYT, BOLD, OCUL, CBAY 13F-HR 22 Jan 2019, 16:53
Q3 2018 10 $294,005,109 +$34,934,844 $0 +$34,934,844 CRSP, BOLD, VCYT, OCUL, CBAY 13F-HR 05 Oct 2018, 16:19
Q2 2018 9 $320,525,517 +$181,857 -$58,605,344 -$58,423,487 CRSP, BOLD, OCUL, CBAY, AKAOQ 13F-HR 13 Jul 2018, 15:40
Q1 2018 8 $312,675,947 +$210,551,322 $0 +$210,551,322 CRSP, BOLD, AKAOQ, OCUL, CBAY 13F-HR 03 May 2018, 16:43
Q4 2017 7 $95,029,118 $0 -$19,609,835 -$19,609,835 BOLD, AKAOQ, OCUL, CBAY, IMDZ 13F-HR 25 Jan 2018, 14:57
Q3 2017 8 $131,378,620 $0 $0 $0 BOLD, IMDZ, AKAOQ, OCUL, CLVSQ 13F-HR 13 Oct 2017, 11:52
Q2 2017 8 $127,127,265 $0 -$28,628,010 -$28,628,010 BOLD, AKAOQ, IMDZ, OCUL, CLVSQ 13F-HR 02 Aug 2017, 12:13
Q1 2017 8 $137,509,477 +$8,373,843 -$2,449,980 +$5,923,863 AKAOQ, BOLD, CLVSQ, OCUL, IMDZ 13F-HR 07 Apr 2017, 13:59
Q4 2016 7 $102,740,818 $0 $0 $0 BOLD, OCUL, CLVSQ, AKAOQ, IMDZ 13F-HR 18 Jan 2017, 14:47
Q3 2016 7 $89,691,642 +$48,917,910 -$94,937,131 -$46,019,221 BOLD, IMDZ, OCUL, CLVSQ, AKAOQ 13F-HR 24 Oct 2016, 06:01
Q2 2016 5 $98,672,514 $0 -$67,480,432 -$67,480,432 GKOS, OCUL, CLVSQ, AKAOQ, CBAY 13F-HR 28 Jul 2016, 16:21
Q1 2016 7 $138,515,846 $0 $0 $0 GKOS, FPRX, OCUL, CLVSQ, BITI 13F-HR 25 Apr 2016, 14:10
Q4 2015 7 $170,904,743 $0 -$148,052 -$148,052 GKOS, FPRX, OCUL, CLVSQ, AKAOQ Restatement 05 May 2016, 13:15
Q3 2015 7 $174,363,358 +$107,158,528 $0 +$107,158,528 GKOS, CLVSQ, OCUL, FPRX, AKAOQ 13F-HR 28 Oct 2015, 13:33
Q2 2015 5 $78,844,234 +$5,365,379 -$44,300,697 -$38,935,318 CLVSQ, FPRX, AKAOQ, BITI, CBAY 13F-HR 15 Jul 2015, 15:38
Q1 2015 6 $113,697,981 +$4,967,535 $0 +$4,967,535 CLVSQ, FPRX, AKAOQ, CBAY, INGN 13F-HR 23 Apr 2015, 17:01
Q4 2014 5 $104,586,174 $0 $0 $0 CLVSQ, FPRX, AKAOQ, CBAY, KYTH Restatement 23 Apr 2015, 16:13